Tirzepatide 20mg (5-Pack)
High-Dose Bundle — Extended Maintenance Supply
Five 20mg tirzepatide vials — higher-dose format for researchers who have titrated above the standard 15mg ceiling. Exceptional value for advanced maintenance-phase research programs.
Starting From
$699.99
Sold By
Apollo Peptide Sciences
Suggested Protocol
For researchers operating at 10–20mg weekly dosing. Reconstitute with bacteriostatic water to desired working concentration (e.g., 2ml per vial for 10mg/ml). SubQ injection once weekly. Refrigerate reconstituted vials immediately; store sealed vials at room temperature or refrigerated. Use reconstituted vials within 28 days.
22.5%
Body Wt. Loss
5 × 20 mg
Total Supply
Up to 20 mg
High Dose
More Volume Per Vial, More Flexibility — High-Dose Tirzepatide Research Made Practical
The Tirzepatide 20mg 5-Pack delivers five higher-volume 20mg vials in a single bundled purchase, designed for researchers whose maintenance protocols operate above the standard 15mg dose ceiling explored in SURMOUNT-1. Each 20mg vial provides greater per-vial supply flexibility for researchers at 10–20mg weekly dosing, enabling precise reconstitution at higher concentrations or accommodating protocol flexibility without the overhead of managing multiple smaller vials simultaneously.
At 10mg weekly dosing, each 20mg vial provides two weeks of supply; at 15mg weekly, each vial covers approximately 10 days; at higher experimental doses, the 20mg vial delivers a meaningful single-vial supply buffer. The 5-pack consolidates five of these high-dose vials into a single order — eliminating frequent reordering and delivering cost savings over individual 20mg purchases.
Tirzepatide's dual GLP-1/GIP mechanism produces its metabolic and body composition effects through sustained, consistent dosing. The 5-pack's extended supply horizon ensures that researchers at any dose within the 10–20mg weekly range can maintain uninterrupted protocol continuity — the prerequisite for observing tirzepatide's cumulative effects on visceral fat, insulin sensitivity, and metabolic markers.
Above the Clinical Ceiling
What Researchers Are Exploring Above the 15mg SURMOUNT-1 Maximum
SURMOUNT-1 tested tirzepatide up to 15mg weekly — not because 15mg was believed to be the maximum effective dose, but because it was the maximum dose in the study protocol. Some researchers are exploring higher doses in individual protocols, hypothesizing that the GLP-1/GIP dual mechanism may continue to produce incremental benefits above 15mg in specific populations. The 20mg vial format exists precisely for this exploratory research — providing a single-vial supply for researchers at 15–20mg weekly without the inconvenience of drawing from two separate 15mg vials per dose.
Vial Volume Flexibility
How the 20mg Format Changes Your Reconstitution and Concentration Options
The higher compound volume per vial means you can reconstitute to a wider range of working concentrations. At 2ml BAC water: 10mg/ml (flexible for both 10mg and 15mg weekly dosing). At 1ml: 20mg/ml (very concentrated, allows small injection volume at high doses). At 4ml: 5mg/ml (useful if working with researchers who prefer larger injection volumes). The 15mg vials are fixed at 15mg maximum per vial regardless of reconstitution — the 20mg format provides the additional headroom for precise concentration engineering across a wider dose range.
Who This Format Is For
When Standard 15mg Vials Are No Longer the Efficient Supply Choice
If your established weekly dose is 10mg, the 15mg vial provides one and a half doses per vial — requiring half-vial bookkeeping and slightly awkward protocol math. The 20mg vial provides exactly two doses at 10mg weekly: cleaner math, cleaner protocol. If your dose is 15mg weekly, you're getting one injection per 15mg vial (the same as the standard format) but with 5mg of unused capacity unless you're cycling. The 20mg vial is the right format for researchers whose maintenance dose creates inefficiency or waste with the standard 15mg unit.
Key Benefits
5 high-dose 20mg vials — flexible supply for researchers at 10–20mg weekly dosing
Greater per-vial compound volume vs. standard 15mg format for extended single-vial use
Bundle pricing provides cost savings vs. five individual 20mg purchases
Accommodates higher-dose research protocols above the standard 15mg ceiling
Supports 2+ weeks of supply per vial at 10mg weekly dosing
Single order eliminates reordering overhead across a sustained research block
Compatible with bacteriostatic water for any working concentration
Dual GLP-1/GIP receptor agonism for comprehensive metabolic research
Full Protocol
For researchers operating at 10–20mg weekly dosing. Reconstitute with bacteriostatic water to desired working concentration (e.g., 2ml per vial for 10mg/ml). SubQ injection once weekly. Refrigerate reconstituted vials immediately; store sealed vials at room temperature or refrigerated. Use reconstituted vials within 28 days.
Best Stacked With
More in Weight Management
View All
Semaglutide
The compound behind Ozempic/Wegovy. GLP-1 receptor agonist producing significant appetite suppression, fat loss, and metabolic improvement with once-weekly dosing.
